576 related articles for article (PubMed ID: 16308242)
1. Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Corne P; Marchandin H; Macia JC; Jonquet O
Scand J Infect Dis; 2005; 37(11-12):946-9. PubMed ID: 16308242
[TBL] [Abstract][Full Text] [Related]
2. Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid.
Ruiz ME; Guerrero IC; Tuazon CU
Clin Infect Dis; 2002 Oct; 35(8):1018-20. PubMed ID: 12355391
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Bassetti M; Di Biagio A; Del Bono V; Cenderello G; Bassetti D
Int J Antimicrob Agents; 2004 Jul; 24(1):83-4. PubMed ID: 15225867
[TBL] [Abstract][Full Text] [Related]
5. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
[TBL] [Abstract][Full Text] [Related]
6. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
Vernadakis S; Saner FH; Rath PM; Kaiser GM; Mathe Z; Treckmann J; Paul A
Transpl Infect Dis; 2009 Aug; 11(4):346-8. PubMed ID: 19497075
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Joson J; Grover C; Downer C; Pujar T; Heidari A
J Antimicrob Chemother; 2011 Sep; 66(9):2186-8. PubMed ID: 21653600
[No Abstract] [Full Text] [Related]
8. Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid.
Balkhair A; Al Muharrmi Z; Darwish L; Farhan H; Sallam M
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e227-9. PubMed ID: 20005763
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Dailey CF; Dileto-Fang CL; Buchanan LV; Oramas-Shirey MP; Batts DH; Ford CW; Gibson JK
Antimicrob Agents Chemother; 2001 Aug; 45(8):2304-8. PubMed ID: 11451689
[TBL] [Abstract][Full Text] [Related]
10. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of Staphylococcus epidermidis prosthetic valve endocarditis with linezolid after failure of treatment with oxacillin, gentamicin, rifampicin, vancomycin, and fusidic acid regimens.
de Feiter PW; Jacobs JA; Jacobs MJ; Vink C; van der Geest S
Scand J Infect Dis; 2005; 37(3):173-6. PubMed ID: 15849048
[TBL] [Abstract][Full Text] [Related]
12. Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis treated with linezolid.
Mancino P; Ucciferri C; Falasca K; Pizzigallo E; Vecchiet J
Scand J Infect Dis; 2008; 40(1):67-73. PubMed ID: 17852941
[TBL] [Abstract][Full Text] [Related]
13. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
Itani KM; Weigelt J; Li JZ; Duttagupta S
Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
[TBL] [Abstract][Full Text] [Related]
14. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
De Gascun C; Rajan L; O'Neill E; Smyth EG
J Antimicrob Chemother; 2006 Jan; 57(1):150-1. PubMed ID: 16244085
[No Abstract] [Full Text] [Related]
15. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
16. No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
Wegner DL
MLO Med Lab Obs; 2005 Jan; 37(1):26-9. PubMed ID: 15743145
[No Abstract] [Full Text] [Related]
17. Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Chiang FY; Climo M
Antimicrob Agents Chemother; 2003 Sep; 47(9):3002-4. PubMed ID: 12937013
[TBL] [Abstract][Full Text] [Related]
18. Methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE) in a patient with Job's syndrome (hyperimmunoglobulin E syndrome) successfully treated with linezolid and high-dose daptomycin.
Cunha BA; Krol V; Kodali V
Heart Lung; 2008; 37(1):72-5. PubMed ID: 18206530
[TBL] [Abstract][Full Text] [Related]
19. Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain.
Hentschke M; Saager B; Horstkotte MA; Scherpe S; Wolters M; Kabisch H; Grosse R; Heisig P; Aepfelbacher M; Rohde H
Infection; 2008 Feb; 36(1):85-7. PubMed ID: 18165857
[No Abstract] [Full Text] [Related]
20. Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant Staphylococcus aureus with linezolid.
Souli M; Pontikis K; Chryssouli Z; Galani I; Giamarellou H
Eur J Clin Microbiol Infect Dis; 2005 Nov; 24(11):760-2. PubMed ID: 16283218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
